SCHEMBL6280001

SCHEMBL6280001

CC(C(N)=O)C1CCNc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ F12 P00748 20/20 0.43
▸ F2 P00734 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5501925 0.80 EPHX2 (0.44) —
SCHEMBL24090522 0.79 AR (0.40) F12
SCHEMBL13059131 0.79 AR (0.40) F12
SCHEMBL18886131 0.79 AR (0.40) F12
SCHEMBL19457862 0.77 F12 (0.37) F12F2
SCHEMBL17075166 0.76 KDM1A (0.34) F12
SCHEMBL22050033 0.76 KDM1A (0.34) F12
SCHEMBL22050044 0.76 KDM1A (0.34) F12
SCHEMBL15882481 0.74 TRPM8 (0.44) —
SCHEMBL17335654 0.74 TRPM8 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556047-A2 PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES MILLENNIUM PHARMACEUTICALS, INC. (US) 2005-07-27 — — EP disclosed
WO-2004032848-A2 PGD2 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES MILLENNIUM PHARMACEUTICALS, INC. (US) 2004-04-22 — — WO disclosed
Send feedback